Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q2 2017 · 10-Q
Revenue$220.25M$220.25M+0.3% vs Q2 2016 Net Income$19.83M$19.83M+54.1% vs Q2 2016 EPS Diluted$0.38$0.38+52.0% vs Q2 2016 Gross Profit$104,248,000−1.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$39,265,000+42.7% Free Cash Flowderived$20,120,000+1,136.6% Margins · derivedGross margin47.3%−0.6 pt vs Q2 2016
Operating margin11.3%+2.5 pt vs Q2 2016
Net margin9.0%+3.1 pt vs Q2 2016
ended Oct 1, 2016 · filed Nov 7, 2016 · 37 d after period end